OncoSil files for TGA registration
Filed with ASX · · 2 pages · English
Earlier from OncoSil Medical
- OncoSil receives Singapore regulatory approval
- Allotment of Securities under Institutional Placement
- Proposed issue of Securities - OSL
- Oncosil breakthrough device receives CE Marking approval
- Clarification Statement
Later from OncoSil Medical
- OncoSil presents clinical data at ESMO World Congress
- HDE filing submitted in US for Bile Duct Cancer treatment
- Preliminary Final Report - Appendix 4E Announcement
- OncoSil receives Malaysian regulatory approval
- Investor Update
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical